Recent Articles from GlobeNewswire

MINNETONKA, Minn., Nov. 06, 2026 (GLOBE NEWSWIRE) -- On November 6, 2026, the Board of Directors of Table Trac Inc. (OTCQX: TBTC) declared a quarterly cash dividend of $0.02 per share on the Company's common stock. The dividend is payable on December 11, 2026, to shareholders of record as of the close of business on November 27, 2026.

CLEVELAND, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it is scheduled to present at the Robert W. Baird Global Industrial Conference in Chicago, Illinois on November 10, 2026 at 10:50 a.m. Central time (11:50 a.m. Eastern time).

MONTREAL, Nov. 06, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis” or “the Company”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces today that it will host a conference call at 11:00 AM Eastern Time on Friday, November 13, 2026 to discuss the Company’s financial results for the third quarter ended September 30, 2026, as well as to provide an update to the Company’s progress and other developments.

Acquisition Expands Confluent's Nitinol Rapid Prototyping And Technical Knowledge While Strengthening Supply Chain Resilience For Next-generation Devices.

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on November 2, 2026 (the “Grant Date”), ORIC granted a total of 14,800 non-qualified stock options and 2,400 restricted stock units to one new non-executive employee who began their employment with ORIC in October 2026.

EDEN PRAIRIE, Minn., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Wednesday, November 11, 2026, at 8:30 AM (ET) to present its Q3 2026 financial results.

Health equity initiative brings expert-led virtual fitness classes, available live and on-demand, to library systems across the country.

BOSTON, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announces that on November 6, Amwell made grants of RSUs covering an aggregate of 5,761 shares of its Class A common stock to two new employees. The grants were offered as material inducement to the employees’ employment with Amwell. The RSUs will vest as follows, subject to the applicable employee’s continued employment through the applicable vesting date: 25% of the RSUs will vest upon the first anniversary of the grant date (“Initial Vesting Date”), and the remaining 75% of the RSUs will vest in equal pro rata increments every three months thereafter (beginning on the first calendar day of the month following the date that is three months following the Initial Vesting Date) for three years until such RSUs are vested in full.

Clinical Preparations Advanced for EB613 Phase 3 Osteoporosis Study, with First Site Activation Expected in Late 2026

MALVERN, Pa., Nov. 06, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 108,550 shares of its common stock to four newly-hired employees, with a grant date of November 4, 2026 (the "Grant Date"). The restricted stock units were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individual's employment compensation and were granted as an inducement material to his or her acceptance of employment with TELA Bio.

BRISBANE, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on November 2, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 14,900 shares of Class A common stock and restricted stock units (RSUs) underlying 7,450 shares of Class A common stock to three (3) new employees under the Vera Therapeutics, Inc. 2024 Inducement Plan (Inducement Plan). The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biotechnology company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today announced that it will host a webcast on Monday, November 9, 2026, at 8:00 a.m. ET, to review initial clinical data from its Ntrust program evaluating NKX019 in myositis and systemic sclerosis being presented at the American College of Rheumatology (ACR) Convergence 2026 in Orlando.

NAARDEN, the Netherlands and MIAMI, Nov. 06, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam’s Board of Directors approved the grant of inducement share options covering an aggregate of 106,600 of NewAmsterdam’s ordinary shares to 6 non-executive new hires. The share options were granted as an inducement material to the employees’ acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4).

PALO ALTO, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that on November 5, 2026, the compensation committee of BridgeBio’s board of directors approved equity grants to 80 new employees in restricted stock units for an aggregate of 147,578 shares of the Company’s common stock. One-fourth of the shares underlying each employee’s restricted stock units will vest on November 16, 2027, with one-twelfth of the remaining shares underlying each such employee’s restricted stock units vesting on a quarterly basis thereafter, in each case, subject to each such employee’s continued employment with the Company or one of its subsidiaries on such vesting dates.

HIGH POINT, N.C., Nov. 06, 2026 (GLOBE NEWSWIRE) -- High Point University welcomed nearly 3,000 veterans, family members and community guests to the Nido and Mariana Qubein Arena and Conference Center today for its 16th Annual Veterans Day Celebration, honoring those men and women who have served and sacrificed for our country.

San Antonio, TX, Nov. 06, 2026 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (Nasdaq: GROW) will host a webcast on Friday, November 13, at 7:30 a.m. Central time to discuss the company’s results for the first quarter of fiscal 2027.

HRS/BHB-1893 demonstrated meaningful improvements in exercise capacity and patient-reported outcomes, with rapid, deep, and durable left ventricular outflow tract (LVOT) gradient reduction at 52 weeks

Just one week away, CIOs, CISOs, CTOs and technology executives from across Tennessee, the Tennessee Valley and Mid-South will gather Nov. 13 at W Nashville to explore AI, cybersecurity, workforce transformation and Iconic Leadership

NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Bank of America Corporation (“Bank of America” or the “Company”) (NYSE: BAC) on behalf of investors that purchased or otherwise acquired Bank of America common stock between August 1, 2025 and October 13, 2026 (the “Class Period”).

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Gildan Activewear Inc. (“Gildan” or the “Company”) (NYSE: GIL) on behalf of investors that purchased or otherwise acquired Gildan securities between February 19, 2025 and June 15, 2026 (the “Class Period”).

NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Ensign Group, Inc. (“Ensign” or the “Company”) (NASDAQ: ENSG) on behalf of investors that purchased or otherwise acquired Ensign securities between February 10, 2022 and June 18, 2026 (the “Class Period”).

NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Millrose Properties, Inc. (“Millrose” or the “Company”) (NYSE: MRP) on behalf of investors that purchased or otherwise acquired Millrose securities between February 7, 2025 and October 2, 2026 (the “Class Period”).

NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Duolingo, Inc. (“Duolingo” or the “Company”) (NASDAQ: DUOL) on behalf of investors that purchased or otherwise acquired Duolingo Class A common stock between May 2, 2025 and February 26, 2026 (the “Class Period”).

NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Coastal Financial Corporation (“Coastal Financial” or the “Company”) (NASDAQ: CCB) on behalf of investors that purchased or otherwise acquired Coastal Financial common stock between October 28, 2024 and July 29, 2026 (the “Class Period”).

New release celebrates the five-year anniversary of Gaethje’s unforgettable UFC 268 fight with Michael Chandler as UFC prepares to return to New York for UFC 334.

NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Alphabet Inc. (“Alphabet” or the “Company”) (NASDAQ: GOOGL, GOOG) on behalf of investors that purchased or otherwise acquired Alphabet securities between May 19, 2026 and July 16, 2026 (the “Class Period”).

NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against AppLovin Corporation (“AppLovin” or the “Company”) (NASDAQ: APP) on behalf of investors that purchased or otherwise acquired AppLovin securities between February 12, 2026 and August 5, 2026 (the “Class Period”).

                               

Total Bankruptcy Filings Increased 2%

WASHINGTON, Nov. 06, 2026 (GLOBE NEWSWIRE) -- The Council of Federal Home Loan Banks today issued the following statement attributable to Council President and CEO Ryan Donovan on the appointment of Adam Goldstein as the new President and CEO of FHLBank New York.

In 17 first-line patients treated with the combination, the estimated two-year overall survival (OS) rate was 70% - Median OS was not reached at a median follow-up of 29 months and 10 patients remained on study

WASHINGTON, D.C., Nov. 06, 2026 (GLOBE NEWSWIRE) -- The United States Mint (Mint) will begin accepting orders for two-roll sets and 100-coin bags of the fifth and last 2026 Semiquincentennial Quarter on November 13, 2026, at noon EST. The coin, featuring the Gettysburg Address, was released into circulation on October 19, 2026. Due to high demand, orders for these products will be limited to two units for each option.

SEATTLE, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced systemic treatments for cancers, today announced updated interim monotherapy results from its ongoing Phase 1/2a clinical trial of [212Pb]lapemelanotide zapixetar (VMT01), an investigational targeted alpha therapy. The Company presented the data as a poster at the Society for Immunotherapy of Cancer (SITC) 41st Annual Meeting, being held November 4 to 8, 2026, in Phoenix, Arizona.

CHARLOTTE, N.C., Nov. 06, 2026 (GLOBE NEWSWIRE) -- QC Capital Group, LLC today announced the addition of Lee Cole as Acquisitions Lead, strengthening the firm's acquisition and development team as it continues expanding its platform of essential businesses across the Southeast.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anavex (AVXL) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Qfin (QFIN) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Endava (DAVA) To Contact Him Directly To Discuss Their Options

AMSTERDAM and PHILADELPHIA, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Akzo Nobel N.V. (AKZA; AKZOY) (“AkzoNobel”) and Axalta Coating Systems Ltd. (NYSE:AXTA) (“Axalta”) today received conditional approval from the European Commission for their proposed all-stock merger of equals, which will create a premier global coatings company. The transaction is expected to close in early 2027 subject to pending regulatory approvals.

ST. PETERSBURG, Fla., Nov. 06, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Superior Group of Companies, Inc. (NASDAQ: SGC) today announced that it has declared a quarterly dividend of $0.14 per share, payable November 25, 2026, to shareholders of record as of November 16, 2026.

TORONTO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today announced that, further to the Company’s news release dated September 28, 2026, the Company has filed a National Instrument 43-101 technical report for its Snow Lake operations in Manitoba (the “2026 Technical Report”).

If you purchased or acquired Fluence Energy securities between November 24, 2025 and September 16, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.

CINCINNATI, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company’s capital stock, payable on December 4, 2026, to shareholders of record as of November 16, 2026. This is equal to the dividend paid in September 2026. This represents the 222nd consecutive quarterly dividend paid by Chemed in its 55 years as a public company.

Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Honeywell Aerospace (HONA) To Contact Them Directly To Discuss Their Options

MT. OLIVE, N.J., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (OTCID: VISL), a global leader in real-time video communications for the defense, public safety, and broadcast markets, today announced that it will report its financial and operational results for the third quarter ended September 30, 2026, on Friday, November 13, 2026.

Investment supports pathways from military service to skilled careers, family-sustaining wages and long-term economic security

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Better Home (BETR) To Contact Him Directly To Discuss Their Options

- Adam Goldstein brings nearly 30 years of FHLBNY experience to his new role -

LOS ANGELES, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fluence Energy, Inc. (“Fluence” or “the Company”) (NASDAQ: FLNC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Endava plc (“Endava” or “the Company”) (NYSE: DAVA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

LOS ANGELES, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Qfin Holdings, Inc. (“Qfin” or “the Company”) (NASDAQ: QFIN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Seasonal extension of For the Haul of It introduced alongside new Bealls mobile app

YORK, Penn., Nov. 06, 2026 (GLOBE NEWSWIRE) -- The York Water Company's (NASDAQ:YORW) President, JT Hand, announced the Company's financial results for the third quarter and the first nine months of 2026.

Following a compliance inquiry stemming from a prior decision, BBB National Programs’ National Advertising Division will refer Kendal Nutricare Limited to appropriate government and state agencies and advertising platforms for review and possible enforcement action after the company elected not to participate in the compliance inquiry.

NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies, today announced preclinical findings from two studies presented at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC) in Phoenix, Arizona. The studies address two distinct mechanisms by which tumors resist treatment: immune-suppressive metastatic environments that limit checkpoint blockade, and senescent cells that persist after therapy. Together they show how one foundational iNKT biology, in unmodified and engineered form, can be directed against both through tumor-cell killing, immune modulation and engineered targeting.

NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- SunCar Technology Group Inc. (“SunCar” or the “Company”) (NASDAQ: SDA), a Cayman Islands exempted company, today announced that its board of directors has authorized a share repurchase program to buy back up to $10 million of its outstanding Class A ordinary shares, par value $0.0001 per share (the “Class A Ordinary Shares”). This program reflects the Company's confidence in its long-term growth prospects. The share repurchase program is expected for the next three months. The Company intends to fund the repurchases through a combination of cash on hand and cash generated from operations.

LOS ANGELES, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tigo Energy, Inc. (“Tigo” or “the Company”) (NASDAQ: TYGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

SAN FRANCISCO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today announced that it will participate in the following investor conferences.

AI-Powered Narrative Intelligence Will Help Distinguish Authentic Audience Reaction from Coordinated Amplification and Identify Impersonation Threats

Texas family law firm advances to Tier 1 in Appellate Practice, joining its top-tier rankings in Family Law and Family Law Mediation

Public-private partnership to build an annual expo for upwards of 500,000 people on Florida's Space Coast

KIMMTRAK® (tebentafusp-tebn) net revenues of $102.2 million in Q3 2026 and net revenues of $324.8 million for the first nine months of 2026, representing 10% year-over-year growth year to date

BERKELEY, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Azalea Therapeutics, Inc., a biotechnology company redefining precision genomic medicines in vivo, today announced new preclinical data demonstrating durable anti-tumor activity and the versatility of its proprietary in vivo TRAC-CAR T cell platform. The findings, to be presented at the Society for Immunotherapy of Cancer 41st Annual Meeting (SITC 2026), taking place November 4 – 8, 2026, in Phoenix, Arizona, highlight the platform’s ability to generate functional CAR T cells through precise genomic integration, achieve durable tumor control across hematologic and solid tumor models and enable advanced engineering strategies designed to address key limitations of conventional CAR T cell therapies.

ANCHORAGE, Alaska, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Afognak Native Corporation announces the appointment of Autumn Sellars as its Interim CEO effective November 5, 2026. Sellars joined Alutiiq, LLC, a wholly owned subsidiary of Afognak, in 2017 when Alutiiq acquired her company Alcyon, Inc. Prior to her appointment as Interim CEO, Sellars served as Alutiiq’s Operations & Compliance Executive.

SEATTLE, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of financial services that transcend borders, today announced that its management team will present at the following investor conferences:

- Durable complete regressions observed in 50% of mice in a RAS-mutant colorectal cancer model treated with Atebimetinib plus anti-PD-1, with no regrowth even after dosing stopped -

NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. (“Getty Images”) (OTC Pink: GETYQ), the preeminent source of authentic visual content and coverage, confirmed that it will release third quarter 2026 financial results after market close on Monday, November 16, 2026, as scheduled. It will not hold a conference call and webcast in light of the Company's Chapter 11 restructuring process.

Three posters, including a late-breaking presentation, provide new clinical and biomarker data for aglatimagene besadenovec (aglatimagene) in localized prostate cancer and non-small cell lung cancer (NSCLC), and for linoserpaturev in recurrent glioblastoma

The longtime Simpsons writer and progressive Republican presidential candidate will visit Springfields across America to explore shared concerns

2027 payment changes advanced by APA advocacy strengthen mental health treatment in primary care through psychiatrists’ medical expertise

Sold-out philanthropic celebration at New York City’s Ziegfeld Ballroom featured exceptional wines, exclusive experiences, and fundraising in support of the healing power of music

Individual and institutional investors, advisors and analysts can now view presentations online

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

Reaffirms Company’s commitment to strengthening its financial position through deleveraging

10-year renewal secures Gogo’s exclusive nationwide 800 MHz ATG spectrum, the foundation of its North American business aviation network